Peer-reviewedCC BYBiomedicines
Donor-Resolved Analysis of HES1-Associated Fibroblast States in Systemic Sclerosis
- 1The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310053, China;
- 2Innovation Center for Medical Basic Research of Autoimmune Diseases, China National Ministry of Education, College of Basic Medical Science, , Hangzhou 310053, China;
Related
- Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
- Sotatercept-related peripheral microvascular alterations in systemic sclerosis–associated pulmonary arterial hypertension: insights from nailfold capillaroscopy
- Scleroderma Renal Crisis-Associated Thrombotic Microangiopathy Preceding Skin Sclerosis in Diffuse Cutaneous Systemic Sclerosis: A Case Report
- Case Report: Upfront sotatercept-based triple therapy in high-risk systemic sclerosis-associated pulmonary arterial hypertension
- Persistent Bacillus cereus bacteremia in a patient with systemic sclerosis-associated intestinal pseudo-obstruction: A case report.
BibTeX
@article{fang2026donorresolved,
title = {{Donor-Resolved Analysis of HES1-Associated Fibroblast States in Systemic Sclerosis}},
author = {Shenyi Fang and Lin Huang and Mingzhu Wang},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13702352},
note = {CC BY},
}
RIS
TY - JOUR
TI - Donor-Resolved Analysis of HES1-Associated Fibroblast States in Systemic Sclerosis
AU - Shenyi Fang
AU - Lin Huang
AU - Mingzhu Wang
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13702352
SN - 2227-9059
ER -